Muhsen Ibrahim N., ElHassan Tusneem, Hashmi Shahrukh K
Alfaisal University College of Medicine, Riyadh, Saudi Arabia
King Faisal Specialist Hospital and Research Center, Oncology Center, Riyadh, Saudi Arabia
Turk J Haematol. 2018 Aug 3;35(3):152-157. doi: 10.4274/tjh.2018.0123. Epub 2018 Jun 8.
The evidence-based literature on healthcare is currently expanding exponentially. The opportunities provided by the advancement in artificial intelligence (AI) tools such as machine learning are appealing in tackling many of the current healthcare challenges. Thus, AI integration is expanding in most fields of healthcare, including the field of hematology. This study aims to review the current applications of AI in the field of hematopoietic cell transplantation (HCT). A literature search was done involving the following databases: Ovid MEDLINE, including In-Process and other non-indexed citations, and Google Scholar. The abstracts of the following professional societies were also screened: American Society of Hematology, American Society for Blood and Marrow Transplantation, and European Society for Blood and Marrow Transplantation. The literature review showed that the integration of AI in the field of HCT has grown remarkably in the last decade and offers promising avenues in diagnosis and prognosis in HCT populations targeting both pre- and post-transplant challenges. Studies of AI integration in HCT have many limitations that include poorly tested algorithms, lack of generalizability, and limited use of different AI tools. Machine learning techniques in HCT are an intense area of research that needs much development and extensive support from hematology and HCT societies and organizations globally as we believe that this will be the future practice paradigm.
目前,基于证据的医疗保健文献正呈指数级增长。机器学习等人工智能(AI)工具的进步所带来的机遇,对于应对当前许多医疗保健挑战颇具吸引力。因此,AI整合在医疗保健的大多数领域都在不断扩展,包括血液学领域。本研究旨在综述AI在造血细胞移植(HCT)领域的当前应用情况。我们进行了文献检索,涉及以下数据库:Ovid MEDLINE(包括在研和其他未索引的引文)以及谷歌学术。我们还筛选了以下专业协会的摘要:美国血液学会、美国血液和骨髓移植学会以及欧洲血液和骨髓移植学会。文献综述表明,在过去十年中,AI在HCT领域的整合有了显著增长,并为针对移植前和移植后挑战的HCT人群的诊断和预后提供了有前景的途径。HCT中AI整合的研究存在许多局限性,包括算法测试不足、缺乏普遍性以及不同AI工具的使用有限。HCT中的机器学习技术是一个活跃的研究领域,需要全球血液学和HCT协会及组织的大力发展和广泛支持,因为我们相信这将成为未来的实践模式。